ClearPoint Neuro Q3 net loss widens 27% to $7.46 million; Q3 revenue rises 36% to $12.1 million
Bitget2026/10/28 20:10- ClearPoint Neuro’s third-quarter net loss widened 27% to $7.46 million, while revenue rose 36% to $12.1 million year over year.
- Neurosurgery navigation and therapy revenue climbed 59% to $5.4 million; capital equipment and software revenue jumped 68% to $1.7 million.
- A partner submitted its first formal BLA for Huntington’s disease treatment.
- The company now expects 2026 revenue between $48 million and $50 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Crypto prices
More
